Press Release AdvanCell to Present Promising Clinical Trial Results of ADVC001, a Novel Lead-212-based PSMA-targeted Alpha Therapy for Prostate Cancer, at ESMO 2025 12 October 2025
Press Release Natera to Present 14 Studies at ESMO, Including IMvigor011 Oral Presentation in Presidential Symposium 12 October 2025
Press Release Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric Study 12 October 2025
Press Release Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025 12 October 2025
Press Release Leonardo DRS Unveils SAGEcore™ Ruggedized AI Software Platform for Real-time Threat Detection and Decision Support at the Tactical Edge 12 October 2025
Press Release INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of WPP 12 October 2025
Press Release INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma 12 October 2025
Press Release Stitch Fix, Inc. Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – SFIX 12 October 2025
